Search results for " Preschool."

showing 10 items of 2092 documents

Bayesian joint modeling for assessing the progression of chronic kidney disease in children.

2016

Joint models are rich and flexible models for analyzing longitudinal data with nonignorable missing data mechanisms. This article proposes a Bayesian random-effects joint model to assess the evolution of a longitudinal process in terms of a linear mixed-effects model that accounts for heterogeneity between the subjects, serial correlation, and measurement error. Dropout is modeled in terms of a survival model with competing risks and left truncation. The model is applied to data coming from ReVaPIR, a project involving children with chronic kidney disease whose evolution is mainly assessed through longitudinal measurements of glomerular filtration rate.

Statistics and ProbabilityEpidemiologyComputer scienceBayesian probability030232 urology & nephrologyRenal function01 natural sciences010104 statistics & probability03 medical and health sciences0302 clinical medicineHealth Information ManagementStatisticsEconometricsmedicineHumans0101 mathematicsRenal Insufficiency ChronicChildJoint (geology)Dropout (neural networks)Survival analysisAutocorrelationBayes Theoremmedicine.diseaseMissing dataSurvival AnalysisChild PreschoolDisease ProgressionKidney diseaseStatistical methods in medical research
researchProduct

A hierarchical Bayesian birth cohort analysis from incomplete registry data: evaluating the trends in the age of onset of insulin-dependent diabetes …

2005

Childhood diabetes is one of the major non-communicable diseases in children under 15 years of age. It requires a life-long insulin treatment and may lead to serious complications. Along with the worldwide increase in the incidence several countries have recently reported a decreasing trend in the age of onset of the disease. The aim of this study is to analyse long-term data on the incidence of the childhood diabetes in Finland from the birth cohorts perspective. The annual incidence data were available for the period 1965--1996 which translates into 1951--1996 birth cohorts. Hence the data consist of completely and partially observed cohorts. Bayesian modelling was employed in the analysi…

Statistics and ProbabilityMaleAdolescentEpidemiologymedicine.medical_treatmentDiseaseCohort StudiesDiabetes mellitusMedicineHumansAge of OnsetChildFinlandModels Statisticalbusiness.industryInsulinIncidence (epidemiology)Bayes Theoremmedicine.diseaseMissing dataMarkov ChainsDiabetes Mellitus Type 1Child PreschoolCohortFemaleAge of onsetbusinessMonte Carlo MethodCohort studyDemographyStatistics in medicine
researchProduct

Safety of sublingual immunotherapy started during the pollen season

2009

Sublingual immunotherapy (SLIT) is safer than subcutaneous immunotherapy (SCIT) and this has lead to the reconsideration of the use of ultra-rush schedules for SLIT. The aim of this study was to assess the safety of ultra-rush SLIT in pollen-allergic children according to different timing of administration in relation to the pollen season.In total, 34 children with pollen-induced rhinitis and 36 with pollen-induced asthma and rhinitis, were enrolled and assigned to three study groups: group 1 (n = 17 patients): conventional pre-seasonal-SLIT treatment; group 2 (n = 23 patients), seasonal SLIT ended before the pollen seasonal peak; group 3 (n = 30 patients), SLIT began after the pollen seaso…

Study groupsmedicine.medical_specialtyPediatricsAdolescentAdministration SublingualPollen Allergymedicine.disease_causePollenotorhinolaryngologic diseasesmedicineSubcutaneous immunotherapyHumansRhinitis Allergic Seasonal; Humans; Allergens; Asthma; Desensitization Immunologic; Child; Adolescent; Administration Sublingual; Pollen; Child PreschoolSublingual immunotherapyChildAsthmaPollen seasonbusiness.industryAllergenRhinitis Allergic Seasonalfood and beveragesGeneral MedicineAllergensmedicine.diseaseSlitAsthmaeye diseasesSurgerySLIT Ultra-RUSHDesensitization ImmunologicChild PreschoolPollensense organsbusinessHuman
researchProduct

Easy removal of a large mucus plug with a flexible paediatric bronchoscope after administration of rhDNase (Pulmozyme).

2006

Mucoid impaction and plastic bronchitis are relatively rare disorders affecting patients of any age. Here we report the case of mucoid impaction developing in a four-year-old child as a complication of pneumonic infection treated four weeks prior. p.a. chest X-ray and fiberoptic bronchoscopy showed atelectasis and the location of a mucus cast in the left upper lobe. After extraction of the cast via the suction channel of the bronchoscope had failed, we administered 2.5 mg of undiluted recombinant human deoxyribonuclease (rhDNase) instilled directly over the affected area of occlusion for 15 minutes. This mucolytic agent mobilized the cast by reducing viscoelasticity and adherence of mucus. …

Suction (medicine)Malemedicine.medical_specialtyPulmonary AtelectasisTime FactorsPlastic bronchitisAtelectasisMedicineDeoxyribonuclease IHumansBronchitisExpectorantsMucolytic Agentbusiness.industrymedicine.diseaseMucusRecombinant ProteinsSurgeryMucusBronchoscopesTreatment OutcomeAnesthesiaChild PreschoolPediatrics Perinatology and Child HealthLeft upper lobeRadiography ThoracicMucoid impactionbusinessComplicationFollow-Up StudiesKlinische Padiatrie
researchProduct

HNRNPR Variants that Impair Homeobox Gene Expression Drive Developmental Disorders in Humans

2019

The heterogeneous nuclear ribonucleoprotein (HNRNP) genes code for a set of RNA-binding proteins that function primarily in the spliceosome C complex. Pathogenic variants in these genes can drive neurodegeneration, through a mechanism involving excessive stress-granule formation, or developmental defects, through mechanisms that are not known. Here, we report four unrelated individuals who have truncating or missense variants in the same C-terminal region of hnRNPR and who have multisystem developmental defects including abnormalities of the brain and skeleton, dysmorphic facies, brachydactyly, seizures, and hypoplastic external genitalia. We further identified in the literature a fifth ind…

TBX1MaleSpliceosomeHeterogeneous nuclear ribonucleoproteinDevelopmental DisabilitiesRNA SplicingBiologyHeterogeneous-Nuclear Ribonucleoproteins/geneticsHeterogeneous-Nuclear RibonucleoproteinsArticleWhole Exome Sequencing03 medical and health sciences0302 clinical medicineExome SequencingGeneticsHumansGenes Homeobox/geneticsPreschoolHox geneChildGeneTranscription factorGenetics (clinical)RNA Splicing/genetics030304 developmental biologyGeneticsFibroblasts/metabolism0303 health sciencesHomeobox/geneticsGenes HomeoboxInfantFibroblastsOxidative StressPhenotypeGenesDevelopmental Disabilities/etiologyGene Expression RegulationChild PreschoolRNA splicingMutationHomeoboxFemale030217 neurology & neurosurgery
researchProduct

Technetium-99m mercaptoacetyltriglycine clearance: reference values for infants and children.

1995

Six hundred and thirty-nine clearance studies performed in children aged 7 days to 19 years utilizing technetium-99m mercaptoacetyltriglycine (MAG 3) were retrospectively analysed. Standardized conditions for the investigation included: parenteral hydration (60 ml/hxm2 body surface) in addition to normal oral fluid intake, weight-related dose of99mTc-MAG 3 (1 MBq/kg body weight, minimum 15 MBq) and calculation of clearance according to Bubeck et al. Of the 513 children, 169 included in this analysis could be classified as “normal” with regard to their renal function. Normal kidney function was judged by the following criteria: normal GFR for age, normal tubular function (absence of proteinu…

Technetium-99m-MercaptoacetyltriglycineAdultmedicine.medical_specialtyAdolescentUrologychemistry.chemical_elementRenal functionTechnetiumKidneyTechnetium Tc 99m MertiatideReference ValuesmedicineHumansRadiology Nuclear Medicine and imagingChildRetrospective StudiesProteinuriabusiness.industryRefluxInfant NewbornInfantGeneral MedicineSurgerychemistryEl NiñoReference valuesChild PreschoolUltrasonographymedicine.symptombusinessGlomerular Filtration RateEuropean journal of nuclear medicine
researchProduct

A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy)

2019

Abstract Influenza season started in Italy during the month of October 2018, approaching the epidemic peak in January 2019. This report aim to explore the mid-term virologic surveillance data of the 2018–2019 influenza season in Sicily and to estimate the effectiveness of seasonal influenza vaccine (VE) against A(H1N1)pdm09 and A(H3N2) influenza viruses. A test-negative design was used to evaluate influenza VE. In Sicily, almost all influenza infections were sustained by influenza type A viruses, of which 62.3% were A(H3N2) and 36.3% A(H1N1)pdm09. A reduction of laboratory confirmed influenza cases in Sicilian population immunized against influenza were observed. In particular, an overall s…

Test-negative designAdultMaleVeterinary medicineSurveillance dataAdolescent030231 tropical medicinePopulationInfluenza seasonSurveillance networkSeasonal influenzaYoung Adult03 medical and health sciencesInfluenza A Virus H1N1 Subtype0302 clinical medicineInfluenza vaccine effectiveneInfluenza HumanHumansMedicine030212 general & internal medicineChildeducationSicilyVaccine PotencyAgededucation.field_of_studyGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryInfluenza A Virus H3N2 SubtypeInfluenza epidemicVaccinationPublic Health Environmental and Occupational HealthInfantvirus diseasesInfluenza aLaboratory confirmed caseMiddle AgedA h1n1 pdm09Infectious DiseasesInfluenza viruseInfluenza VaccinesCase-Control StudiesChild PreschoolMolecular MedicineFemaleImmunizationbusinessVaccine
researchProduct

Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study.

2014

To access publisher's full text version of this article. Please click on the hyperlink in Additional Links field. Survival and cure rates for childhood cancers in Europe have greatly improved over the past 40 years and are mostly good, although not in all European countries. The EUROCARE-5 survival study estimates survival of children diagnosed with cancer between 2000 and 2007, assesses whether survival differences among European countries have changed, and investigates changes from 1999 to 2007. We analysed survival data for 157,499 children (age 0-14 years) diagnosed between Jan 1, 1978 and Dec 31, 2007. They came from 74 population-based cancer registries in 29 countries. We calculated …

Time FactorsAdolescentPopulationChildhood cancerMEDLINEBörnNOmedicineChildhood cancer survivalHumansUnglingarChildeducationddc:613Krabbameinchildhood cancer; Europe; EUROCARE-5Ungbörneducation.field_of_studybusiness.industryHazard ratioConfoundingInfant NewbornInfantCancermedicine.diseaseEuropeEastern europeanInstitutional repositoryOncologyChild PreschoolNýburarsense organsNeoplasms/mortalityNeoplasms/mortality*businessDemography
researchProduct

Mapping child growth failure across low- and middle-income countries

2020

Childhood malnutrition is associated with high morbidity and mortality globally1. Undernourished children are more likely to experience cognitive, physical, and metabolic developmental impairments that can lead to later cardiovascular disease, reduced intellectual ability and school attainment, and reduced economic productivity in adulthood2. Child growth failure (CGF), expressed as stunting, wasting, and underweight in children under five years of age (0–59 months), is a specific subset of undernutrition characterized by insufficient height or weight against age-specific growth reference standards3–5. The prevalence of stunting, wasting, or underweight in children under five is the proport…

Time FactorsDevelopmental DisabilitiesPsychological interventionDistribution (economics)0302 clinical medicinerisk factors030212 general & internal medicineSigns and symptomsWastingChildrenLocal Burden of Disease Child Growth Failure Collaborators2. Zero hungerMultidisciplinaryUnder-five1. No povertyPublic Health Global Health Social Medicine and EpidemiologyA900 Others in Medicine and Dentistry3. Good healthMultidisciplinary SciencesGeographyChild PreschoolScience & Technology - Other TopicsHEALTHUnderweightmedicine.symptomsocial sciencesInfantsAFRICAmedicine.medical_specialtyGeneral Science & TechnologyRJDeveloping countryNutritional StatusWorld Health OrganizationChild Nutrition DisordersArticleSocial sciencesMalnutrició03 medical and health sciencesAGEEnvironmental healthmedicineMortalitatHumansMortalityDeveloping CountriesScience & Technologybusiness.industryPublic healthMORTALITYBody WeightMalnutritionInfant NewbornInfantChild growth failuremedicine.diseasesigns and symptomsMalnutritionFolkhälsovetenskap global hälsa socialmedicin och epidemiologiRisk factorsWEIGHTbusinessRA030217 neurology & neurosurgery
researchProduct

IMMUNOGENICITY OF AN ACELLULAR PERTUSSIS VACCINE COMPOSED OF GENETICALLY INACTIVATED PERTUSSIS TOXIN COMBINED WITH FILAMENTOUS HEMAGGLUTININ AND PERT…

1993

We studied the immunogenicity of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin (PT-9K/129G), filamentous haemagglutinin, and a 69-kilodalton protein, pertactin, in 30 children aged 12 to 24 months and in 80 infants aged 2 to 4 months. A significant increase of the neutralizing titer and of the titers against pertussis toxin, filamentous hemagglutinin, and pertactin, as determined by enzyme-linked immunosorbent assay, was achieved after three doses of vaccine in all the children; a significant increase of these antibody titers was obtained in 100%, 96.1%, 93.5%, and 98.7% of the infants, respectively.

Time FactorsFilamentous haemagglutinin adhesinPertussis toxincomplex mixturesBordetella pertussisMicrobiologyNeutralization TestsHumansMedicineVirulence Factors BordetellaAdhesins BacterialImmunization ScheduleWhooping coughPertussis VaccineAntigens Bacterialbusiness.industryImmunogenicitypertussisAntibody titerInfantmedicine.diseaseAntibodies BacterialVirologyVaccinationTiterHemagglutininsPertussis ToxinVaccines InactivatedChild PreschoolImmunoglobulin GPediatrics Perinatology and Child HealthDrug EvaluationPertactinbusinessVaccinepertussis; VaccineBacterial Outer Membrane Proteins
researchProduct